|
WO2016066634A2
|
|
Use of ccr5 antagonists alone or in combination therapy for the treatment of cancer
|
|
WO2016050835A2
|
|
Selective inhibitors of neutrophil elastase for treating neuropathic pain and chronic pain states harbouring a neuropathic component
|
|
WO2016037985A1
|
|
Construct for the delivery of a molecule into the cytoplasm of a cell
|
|
WO2016026919A1
|
|
Vaccines and manufacturing methods for treatment and prevention of disease
|
|
WO2015181303A1
|
|
Method and enzyme solution for flow-cytometric detection of light chain restriction
|
|
WO2015144688A1
|
|
Host dependency factors as targets for antiviral therapy
|
|
EP3006940A1
|
|
Biomarkers for predicting the response to anti-angiogenic cancer therapy
|
|
EP3052118A1
|
|
S100 based treatment of cardiac power failure
|
|
DE102014011857A1
|
|
Multi-channel detector and method for reading multichannel detectors
|
|
DE102014004772A1
|
|
Surgical device, method of using the surgical device and suture
|
|
EP2926831A1
|
|
CD8+ T-cell epitopes from polyomavirus capsid protein VP1 for vaccination
|
|
EP2915883A1
|
|
Non-invasive assay for early detection of cancer
|
|
WO2014139894A1
|
|
Homoarginine as therapeutic for the reduction of myocardial remodeling
|
|
WO2014122302A1
|
|
In vitro method for cardiovascular risk stratification
|
|
DE102013016487A1
|
|
Process for the preparation of metal-N-heterocyclic carbene complexes
|
|
DE102013014360A1
|
|
Location-sensitive detector with digital evaluation electronics for the detection of photon or particle distributions
|
|
DE102013108935A1
|
|
toothbrush element
|
|
EP2818859A1
|
|
Chromatographic Device and Method
|
|
WO2013190091A1
|
|
CIRCULATING miRNAs AS MARKERS FOR BREAST CANCER
|
|
EP2816356A1
|
|
Treatment of insulin resistance through inhibitors of transcription factor TSC22D4
|
